Voloridge Investment Management
AGL icon

Voloridge Investment Management’s Agilon Health AGL Stock Holding History

Voloridge Investment Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,539
Closed -$7.11M – 1332
2021
Q4 		$7.11M Buy
+10,539
New +$6.41M 0.04% 575

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Voloridge Investment Management's AGL Position: Q1 2022 in Review

Voloridge Investment Management sold out of Agilon Health (AGL) in Q1 2022, closing a stake of 10,539 shares — an estimated $7.11M sold.

Voloridge Investment Management first reported a position in AGL in Q4 2021 and held it in 1 quarter. The position peaked at $7.11M in Q4 2021. 121 funds tracked by Wall St. Rank hold AGL as of Q1 2022.

  • Voloridge Investment Management reported no remaining Agilon Health position as of Q1 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 10,539 Agilon Health shares in Q1 2022, an estimated $7.11M.
  • Voloridge Investment Management first reported a position in Agilon Health in Q4 2021 and held it in 1 quarter.
  • Voloridge Investment Management's Agilon Health position peaked at $7.11M in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Agilon Health as of Q1 2022.

Based on Voloridge Investment Management's 13F filing for Q1 2022, filed 16 May 2022.